Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications

[Display omitted] •Hepatic venovenous communications (HVVC) affect the assessment of portal hypertension.•Presence of HVVC implies better-preserved effective intrahepatic perfusion.•HVVC indicates a favorable prognosis after transjugular intrahepatic portosystemic shunt. Hepatic venovenous communica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of radiology 2024-08, Vol.177, p.111554, Article 111554
Hauptverfasser: Ma, Li, Ma, Jingqin, Zhang, Wen, Yu, Jiaze, Zhang, Zihan, Yang, Minjie, Zhou, Yongjie, Ju, Shuai, Gu, Guoqiang, Luo, Jianjun, Yan, Zhiping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 111554
container_title European journal of radiology
container_volume 177
creator Ma, Li
Ma, Jingqin
Zhang, Wen
Yu, Jiaze
Zhang, Zihan
Yang, Minjie
Zhou, Yongjie
Ju, Shuai
Gu, Guoqiang
Luo, Jianjun
Yan, Zhiping
description [Display omitted] •Hepatic venovenous communications (HVVC) affect the assessment of portal hypertension.•Presence of HVVC implies better-preserved effective intrahepatic perfusion.•HVVC indicates a favorable prognosis after transjugular intrahepatic portosystemic shunt. Hepatic venovenous communications (HVVC) is detectable in more than one-third of cirrhotic patients, where portal hypertension (PHT) tends to present more severely. We aimed to explore the prognostic implications of HVVC in patients with sinusoidal PHT treated by transjugular intrahepatic portosystemic shunt (TIPS). The multicenter data of patients (2020–2022) undergoing balloon-occluded hepatic venography during TIPS were retrospectively analyzed. Pre-TIPS total bile acids (TBA) levels in portal, hepatic and peripheral veins were compared between groups. The primary endpoint was the development of overt hepatic encephalopathy (HE) within one year after TIPS. 183 patients were eligible and classified by the presence (n = 69, 37.7 %) or absence (n = 114, 62.3 %) of HVVC. The agreement between wedged hepatic venous pressure and portal venous pressure was poor in HVVC group (intraclass correlation coefficients [ICC]: 0.141, difference: 13.4 mmHg, p 
doi_str_mv 10.1016/j.ejrad.2024.111554
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065986503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0720048X24002705</els_id><sourcerecordid>3065986503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-48116ee74ba2083854b5ad529a8260297d8e5d22f68e5caf4c7b6bb7522ad5c53</originalsourceid><addsrcrecordid>eNp9kc-OFCEQxonRuOPqE5gYjl56FuimoQ8ezMY_m2xiYjTxRmiodmi7oQV6zDyM7yrt7Hj0QIqifl8V8CH0kpI9JbS9GfcwRm33jLBmTynlvHmEdlQKVgnBxGO0I4KRijTy2xV6ltJICOFNx56iq1pKXorNDv3-DHY1YHF06QcOAw5HiBkfYNHZGQzewHLQUyjp4YS1t9hC2WI9ZIg4R-3TuH5fJx2x8yW9CJcQc0inlGEuWTqsPhcAb0XwOeFfrjS5wEfwYVtrwibM8-qdKefBp-foyaCnBC8e4jX6-v7dl9uP1f2nD3e3b-8rU5MuV42ktAUQTa8ZkbXkTc-15azTkrWEdcJK4JaxoS3R6KExom_7XnDGCmZ4fY1en_suMfxcIWU1u2RgmrSHcitVk5Z3suWkLmh9Rk0MKUUY1BLdrONJUaI2X9So_vqiNl_U2ZeievUwYO1nsP80FyMK8OYMQHnm0UFUybjt962LYLKywf13wB8DHKSa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065986503</pqid></control><display><type>article</type><title>Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications</title><source>Elsevier ScienceDirect Journals</source><creator>Ma, Li ; Ma, Jingqin ; Zhang, Wen ; Yu, Jiaze ; Zhang, Zihan ; Yang, Minjie ; Zhou, Yongjie ; Ju, Shuai ; Gu, Guoqiang ; Luo, Jianjun ; Yan, Zhiping</creator><creatorcontrib>Ma, Li ; Ma, Jingqin ; Zhang, Wen ; Yu, Jiaze ; Zhang, Zihan ; Yang, Minjie ; Zhou, Yongjie ; Ju, Shuai ; Gu, Guoqiang ; Luo, Jianjun ; Yan, Zhiping</creatorcontrib><description>[Display omitted] •Hepatic venovenous communications (HVVC) affect the assessment of portal hypertension.•Presence of HVVC implies better-preserved effective intrahepatic perfusion.•HVVC indicates a favorable prognosis after transjugular intrahepatic portosystemic shunt. Hepatic venovenous communications (HVVC) is detectable in more than one-third of cirrhotic patients, where portal hypertension (PHT) tends to present more severely. We aimed to explore the prognostic implications of HVVC in patients with sinusoidal PHT treated by transjugular intrahepatic portosystemic shunt (TIPS). The multicenter data of patients (2020–2022) undergoing balloon-occluded hepatic venography during TIPS were retrospectively analyzed. Pre-TIPS total bile acids (TBA) levels in portal, hepatic and peripheral veins were compared between groups. The primary endpoint was the development of overt hepatic encephalopathy (HE) within one year after TIPS. 183 patients were eligible and classified by the presence (n = 69, 37.7 %) or absence (n = 114, 62.3 %) of HVVC. The agreement between wedged hepatic venous pressure and portal venous pressure was poor in HVVC group (intraclass correlation coefficients [ICC]: 0.141, difference: 13.4 mmHg, p &lt; 0.001), but almost perfect in non-HVVC group (ICC: 0.877, difference: 0.4 mmHg, p = 0.152). At baseline, patients with HVVC had lower Model for end-stage liver disease scores (p &lt; 0.001), blood ammonia levels (p &lt; 0.001), TBA concentrations in the hepatic (p = 0.011) and peripheral veins (p = 0.049) rather than in the portal veins (p = 0.516), and a higher portosystemic pressure gradient (p = 0.035), suggesting more effective intrahepatic perfusion in this group. Within 1-year post-TIPS, HVVC group had a lower incidence of overt HE (11.7 % vs. 30.5 %, p = 0.004, HR: 0.34, 95 % CI: 0.16–0.74, absolute risk difference [ARD]: −17.4) and an improved liver transplantation-free survival rate (97.1 % vs. 86.8 %, p = 0.021, HR: 0.16, 95 % CI: 0.05–0.91, ARD: −10.3). For patients with sinusoidal PHT treated by TIPS, the presence of HVVC was associated with a reduced risk of overt HE and a potential survival benefit.</description><identifier>ISSN: 0720-048X</identifier><identifier>ISSN: 1872-7727</identifier><identifier>EISSN: 1872-7727</identifier><identifier>DOI: 10.1016/j.ejrad.2024.111554</identifier><identifier>PMID: 38850724</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Bile acids ; Decompensated cirrhosis ; Intrahepatic shunting ; Intrahepatic vascular remodeling ; Portal hypertension</subject><ispartof>European journal of radiology, 2024-08, Vol.177, p.111554, Article 111554</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-48116ee74ba2083854b5ad529a8260297d8e5d22f68e5caf4c7b6bb7522ad5c53</cites><orcidid>0000-0003-4942-0439</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0720048X24002705$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38850724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Li</creatorcontrib><creatorcontrib>Ma, Jingqin</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Yu, Jiaze</creatorcontrib><creatorcontrib>Zhang, Zihan</creatorcontrib><creatorcontrib>Yang, Minjie</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Ju, Shuai</creatorcontrib><creatorcontrib>Gu, Guoqiang</creatorcontrib><creatorcontrib>Luo, Jianjun</creatorcontrib><creatorcontrib>Yan, Zhiping</creatorcontrib><title>Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications</title><title>European journal of radiology</title><addtitle>Eur J Radiol</addtitle><description>[Display omitted] •Hepatic venovenous communications (HVVC) affect the assessment of portal hypertension.•Presence of HVVC implies better-preserved effective intrahepatic perfusion.•HVVC indicates a favorable prognosis after transjugular intrahepatic portosystemic shunt. Hepatic venovenous communications (HVVC) is detectable in more than one-third of cirrhotic patients, where portal hypertension (PHT) tends to present more severely. We aimed to explore the prognostic implications of HVVC in patients with sinusoidal PHT treated by transjugular intrahepatic portosystemic shunt (TIPS). The multicenter data of patients (2020–2022) undergoing balloon-occluded hepatic venography during TIPS were retrospectively analyzed. Pre-TIPS total bile acids (TBA) levels in portal, hepatic and peripheral veins were compared between groups. The primary endpoint was the development of overt hepatic encephalopathy (HE) within one year after TIPS. 183 patients were eligible and classified by the presence (n = 69, 37.7 %) or absence (n = 114, 62.3 %) of HVVC. The agreement between wedged hepatic venous pressure and portal venous pressure was poor in HVVC group (intraclass correlation coefficients [ICC]: 0.141, difference: 13.4 mmHg, p &lt; 0.001), but almost perfect in non-HVVC group (ICC: 0.877, difference: 0.4 mmHg, p = 0.152). At baseline, patients with HVVC had lower Model for end-stage liver disease scores (p &lt; 0.001), blood ammonia levels (p &lt; 0.001), TBA concentrations in the hepatic (p = 0.011) and peripheral veins (p = 0.049) rather than in the portal veins (p = 0.516), and a higher portosystemic pressure gradient (p = 0.035), suggesting more effective intrahepatic perfusion in this group. Within 1-year post-TIPS, HVVC group had a lower incidence of overt HE (11.7 % vs. 30.5 %, p = 0.004, HR: 0.34, 95 % CI: 0.16–0.74, absolute risk difference [ARD]: −17.4) and an improved liver transplantation-free survival rate (97.1 % vs. 86.8 %, p = 0.021, HR: 0.16, 95 % CI: 0.05–0.91, ARD: −10.3). For patients with sinusoidal PHT treated by TIPS, the presence of HVVC was associated with a reduced risk of overt HE and a potential survival benefit.</description><subject>Bile acids</subject><subject>Decompensated cirrhosis</subject><subject>Intrahepatic shunting</subject><subject>Intrahepatic vascular remodeling</subject><subject>Portal hypertension</subject><issn>0720-048X</issn><issn>1872-7727</issn><issn>1872-7727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc-OFCEQxonRuOPqE5gYjl56FuimoQ8ezMY_m2xiYjTxRmiodmi7oQV6zDyM7yrt7Hj0QIqifl8V8CH0kpI9JbS9GfcwRm33jLBmTynlvHmEdlQKVgnBxGO0I4KRijTy2xV6ltJICOFNx56iq1pKXorNDv3-DHY1YHF06QcOAw5HiBkfYNHZGQzewHLQUyjp4YS1t9hC2WI9ZIg4R-3TuH5fJx2x8yW9CJcQc0inlGEuWTqsPhcAb0XwOeFfrjS5wEfwYVtrwibM8-qdKefBp-foyaCnBC8e4jX6-v7dl9uP1f2nD3e3b-8rU5MuV42ktAUQTa8ZkbXkTc-15azTkrWEdcJK4JaxoS3R6KExom_7XnDGCmZ4fY1en_suMfxcIWU1u2RgmrSHcitVk5Z3suWkLmh9Rk0MKUUY1BLdrONJUaI2X9So_vqiNl_U2ZeievUwYO1nsP80FyMK8OYMQHnm0UFUybjt962LYLKywf13wB8DHKSa</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Ma, Li</creator><creator>Ma, Jingqin</creator><creator>Zhang, Wen</creator><creator>Yu, Jiaze</creator><creator>Zhang, Zihan</creator><creator>Yang, Minjie</creator><creator>Zhou, Yongjie</creator><creator>Ju, Shuai</creator><creator>Gu, Guoqiang</creator><creator>Luo, Jianjun</creator><creator>Yan, Zhiping</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4942-0439</orcidid></search><sort><creationdate>20240801</creationdate><title>Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications</title><author>Ma, Li ; Ma, Jingqin ; Zhang, Wen ; Yu, Jiaze ; Zhang, Zihan ; Yang, Minjie ; Zhou, Yongjie ; Ju, Shuai ; Gu, Guoqiang ; Luo, Jianjun ; Yan, Zhiping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-48116ee74ba2083854b5ad529a8260297d8e5d22f68e5caf4c7b6bb7522ad5c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bile acids</topic><topic>Decompensated cirrhosis</topic><topic>Intrahepatic shunting</topic><topic>Intrahepatic vascular remodeling</topic><topic>Portal hypertension</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Li</creatorcontrib><creatorcontrib>Ma, Jingqin</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Yu, Jiaze</creatorcontrib><creatorcontrib>Zhang, Zihan</creatorcontrib><creatorcontrib>Yang, Minjie</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Ju, Shuai</creatorcontrib><creatorcontrib>Gu, Guoqiang</creatorcontrib><creatorcontrib>Luo, Jianjun</creatorcontrib><creatorcontrib>Yan, Zhiping</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Li</au><au>Ma, Jingqin</au><au>Zhang, Wen</au><au>Yu, Jiaze</au><au>Zhang, Zihan</au><au>Yang, Minjie</au><au>Zhou, Yongjie</au><au>Ju, Shuai</au><au>Gu, Guoqiang</au><au>Luo, Jianjun</au><au>Yan, Zhiping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications</atitle><jtitle>European journal of radiology</jtitle><addtitle>Eur J Radiol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>177</volume><spage>111554</spage><pages>111554-</pages><artnum>111554</artnum><issn>0720-048X</issn><issn>1872-7727</issn><eissn>1872-7727</eissn><abstract>[Display omitted] •Hepatic venovenous communications (HVVC) affect the assessment of portal hypertension.•Presence of HVVC implies better-preserved effective intrahepatic perfusion.•HVVC indicates a favorable prognosis after transjugular intrahepatic portosystemic shunt. Hepatic venovenous communications (HVVC) is detectable in more than one-third of cirrhotic patients, where portal hypertension (PHT) tends to present more severely. We aimed to explore the prognostic implications of HVVC in patients with sinusoidal PHT treated by transjugular intrahepatic portosystemic shunt (TIPS). The multicenter data of patients (2020–2022) undergoing balloon-occluded hepatic venography during TIPS were retrospectively analyzed. Pre-TIPS total bile acids (TBA) levels in portal, hepatic and peripheral veins were compared between groups. The primary endpoint was the development of overt hepatic encephalopathy (HE) within one year after TIPS. 183 patients were eligible and classified by the presence (n = 69, 37.7 %) or absence (n = 114, 62.3 %) of HVVC. The agreement between wedged hepatic venous pressure and portal venous pressure was poor in HVVC group (intraclass correlation coefficients [ICC]: 0.141, difference: 13.4 mmHg, p &lt; 0.001), but almost perfect in non-HVVC group (ICC: 0.877, difference: 0.4 mmHg, p = 0.152). At baseline, patients with HVVC had lower Model for end-stage liver disease scores (p &lt; 0.001), blood ammonia levels (p &lt; 0.001), TBA concentrations in the hepatic (p = 0.011) and peripheral veins (p = 0.049) rather than in the portal veins (p = 0.516), and a higher portosystemic pressure gradient (p = 0.035), suggesting more effective intrahepatic perfusion in this group. Within 1-year post-TIPS, HVVC group had a lower incidence of overt HE (11.7 % vs. 30.5 %, p = 0.004, HR: 0.34, 95 % CI: 0.16–0.74, absolute risk difference [ARD]: −17.4) and an improved liver transplantation-free survival rate (97.1 % vs. 86.8 %, p = 0.021, HR: 0.16, 95 % CI: 0.05–0.91, ARD: −10.3). For patients with sinusoidal PHT treated by TIPS, the presence of HVVC was associated with a reduced risk of overt HE and a potential survival benefit.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38850724</pmid><doi>10.1016/j.ejrad.2024.111554</doi><orcidid>https://orcid.org/0000-0003-4942-0439</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0720-048X
ispartof European journal of radiology, 2024-08, Vol.177, p.111554, Article 111554
issn 0720-048X
1872-7727
1872-7727
language eng
recordid cdi_proquest_miscellaneous_3065986503
source Elsevier ScienceDirect Journals
subjects Bile acids
Decompensated cirrhosis
Intrahepatic shunting
Intrahepatic vascular remodeling
Portal hypertension
title Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A06%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20risk%20of%20overt%20hepatic%20encephalopathy%20and%20death%20after%20transjugular%20intrahepatic%20portosystemic%20shunt%20in%20patients%20with%20hepatic%20venovenous%20communications&rft.jtitle=European%20journal%20of%20radiology&rft.au=Ma,%20Li&rft.date=2024-08-01&rft.volume=177&rft.spage=111554&rft.pages=111554-&rft.artnum=111554&rft.issn=0720-048X&rft.eissn=1872-7727&rft_id=info:doi/10.1016/j.ejrad.2024.111554&rft_dat=%3Cproquest_cross%3E3065986503%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3065986503&rft_id=info:pmid/38850724&rft_els_id=S0720048X24002705&rfr_iscdi=true